IVERIC bio, Inc. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
IVERIC bio, Inc. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $256.23 million as of 2014-06-30, per its 10-Q filed 2014-08-06.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-08-06
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $256.23M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $203.73M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $183.05M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $162.66M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-06-30 | $256.23M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $203.73M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $183.05M 10-Q · filed 2014-08-06 |
| 2013-09-30 | $162.66M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $126.47M 10-K · filed 2014-03-11 |